EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic

Martin Dreyling; Igor Aurer; Massimo Federico; Mats Jerkeman; Marie Jose Kersten; Kim Linton; Ulrich Mey; Herve Tilly; Christian Buske

doi:10.1097/HS9.0000000000000529

EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic

Martin Dreyling, Igor Aurer, Massimo Federico, Mats Jerkeman, Marie Jose Kersten, Kim Linton, Ulrich Mey, Herve Tilly, Christian Buske

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	e529
Journal	HemaSphere
Volume	5
Issue number	2
DOIs	https://doi.org/10.1097/HS9.0000000000000529
Publication status	Published - 2021
Externally published	Yes

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/HS9.0000000000000529Licence: CC BY-NC-ND

Cite this

@article{4f9cde1216bb4967ace98024c81e4d1e,

title = "EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic",

author = "Martin Dreyling and Igor Aurer and Massimo Federico and Mats Jerkeman and Kersten, {Marie Jose} and Kim Linton and Ulrich Mey and Herve Tilly and Christian Buske",

year = "2021",

doi = "10.1097/HS9.0000000000000529",

language = "English",

volume = "5",

pages = "e529",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer",

number = "2",

}

TY - JOUR

T1 - EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma

T2 - Recommendations for the Second Phase of the COVID-19 Pandemic

AU - Dreyling, Martin

AU - Aurer, Igor

AU - Federico, Massimo

AU - Jerkeman, Mats

AU - Kersten, Marie Jose

AU - Linton, Kim

AU - Mey, Ulrich

AU - Tilly, Herve

AU - Buske, Christian

PY - 2021

Y1 - 2021

U2 - 10.1097/HS9.0000000000000529

DO - 10.1097/HS9.0000000000000529

M3 - Review article

C2 - 33880434

AN - SCOPUS:85104561844

SN - 2572-9241

VL - 5

SP - e529

JO - HemaSphere

JF - HemaSphere

IS - 2

ER -